A covalent BTK ternary complex compatible with targeted protein degradation.

Area of Science:

• Biochemistry
• Chemical Biology
• Drug Discovery

Background:

• Targeted protein degradation via heterobifunctional chimeras offers a strategy to drug the proteome, including proteins lacking enzymatic activity.
• Developing ligands for challenging protein targets remains a significant hurdle in this field.
• Covalent ligands can target proteins but may not always induce a biological response unless they affect protein function.

Purpose of the Study:

• To investigate the role and compatibility of covalent modification in targeted protein degradation.
• To explore the synergy between covalent ligand discovery and chimeric degrader design.
• To validate the mechanism using Bruton's tyrosine kinase as a model target.

Main Methods:

• Utilized a combination of biochemical assays.
• Employed cellular tools and experiments.
• Focused on deconvoluting the impact of covalent modification on protein degradation.

Main Results:

• Demonstrated that covalent target modification is fundamentally compatible with the protein degrader mechanism.
• Provided insights into how covalent interactions influence targeted protein degradation.
• Established Bruton's tyrosine kinase as a viable target for this combined approach.

Conclusions:

• Covalent modification can be effectively integrated into heterobifunctional degrader design.
• This integrated approach expands the potential for targeting previously undruggable proteins.
• The findings advance the fields of targeted protein degradation and covalent drug discovery.